Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes
Marrow stromal cells (MSCs) are in different stages of clinical trials for stroke patients. MSCs are proposed to promote recovery through the release of secretomes that modulate the function of beneficial immune cells. The majority of stroke patients have comorbidities including hypertension, for wh...
Saved in:
Main Authors: | Nikunj Satani (Author), Kaavya Giridhar (Author), Chunyan Cai (Author), Natalia Wewior (Author), Dominique D. Norris (Author), Jaroslaw Aronowski (Author), Sean I. Savitz (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro
by: Nikunj Satani, et al.
Published: (2021) -
Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model
by: Bing Yang, et al.
Published: (2016) -
Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells
by: Paula Laranjeira, et al.
Published: (2015) -
Menstrual blood-derived stromal cells: insights into their secretome in acute hypoxia conditions
by: María Ángeles de Pedro, et al.
Published: (2023) -
The Secretome of Mesenchymal Stromal Cells in Treating Intracerebral Hemorrhage: The First Step to Bedside
by: Stalik Dzhauari, et al.
Published: (2023)